Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 620-365-5 | CAS number: 9016-72-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996/10/15 to 1997/05/09
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Principles of method if other than guideline:
- The administration was via the i.p. route, which is generally not recommended since it is not an intended route of human exposure. Based on evidence of target tissue exposure (altered NCE:PCE ratio) and clear evidence of systemic toxicity, including mortality at 700 mg/kg bw, it is concluded that dosing route was appropriate. Two thousand (2000) instead of recommended 4000 immature erythrocytes per animal were tested, however since the total number of animals tested/ concentration was 10 (instead of the recommended 5), the overall number of analysed cells was concluded to be sufficient.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- polymeric zinc 1,2-propylenebis(dithiocarbamate)
- EC Number:
- 620-365-5
- Cas Number:
- 9016-72-2
- IUPAC Name:
- polymeric zinc 1,2-propylenebis(dithiocarbamate)
- Test material form:
- solid
- Remarks:
- Powder
Constituent 1
- Specific details on test material used for the study:
- The test material was a formulation containing 70% propineb
Test animals
- Species:
- mouse
- Strain:
- other: Hsd/Win
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: approximately 6 to 12 weeks.
- Weight at study initiation: males: 37-44 g, females: 28-34 g
- Housing: The animals were kept singly in type I cages.
- Water: Tap water ad libitum.
- Acclimation period: at least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±1.5
- Humidity (%): 40% to 70%
- Air changes (per hr): 10
Husbandry was standardized, with twelve hours of electrical lighting daily (6.00 hours to 18.00 hours, about 500 lux), 22.5-23°C room temperature, and 47-54% (1st trial) and 33-38% (2nd trial) mean relative humidity. EP IT Elb. 2 (engineering department) gives the following settings for the animal room: 22±1.5°C, 40% to 70% humidity and air change about ten times per hour.
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- Water
- Details on exposure:
- The treated animals received a single intraperitoneal administration of either propineb or cyclophosphamide. The femoral marrow of groups treated with propineb was prepared 16, 24 and 48 hours after administration. All negative and positive control animals were sacrificed after 24 hours. The doses of propineb were 500 mg/kg bw in the first trial and 700 mg/kg bw in the second experiment. For the positive control, cyclophosphamide, 20 mg/kg body weight were used for both studies.
Including both males and females, were intraperitoneally administered 250 mg/kg bw, 500 mg/kg bw and 1000 mg/kg bw of the test material. - Duration of treatment / exposure:
- 24 hours
- Frequency of treatment:
- Once
- Post exposure period:
- 16, 24, 48 hours
Doses / concentrationsopen allclose all
- Dose / conc.:
- 250 mg/kg bw/day
- Remarks:
- First experiment: equivalent to 175 mg/kg bw/d propineb
- Dose / conc.:
- 500 mg/kg bw/day
- Remarks:
- First experiment: equivalent to 350 mg/kg bw/d propineb
- Dose / conc.:
- 1 000 mg/kg bw/day
- Remarks:
- First experiment: equivalent to 700 mg/kg bw/d propineb
- Dose / conc.:
- 500 mg/kg bw/day
- Remarks:
- Second experiment: equivalent to 350 mg/kg bw/d propineb
- Dose / conc.:
- 700 mg/kg bw/day
- Remarks:
- Second experiment: equivalent to 490 mg/kg bw/d propineb
- No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- yes
- Positive control(s):
- 20 mg/kg Cyclophosphamide
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- At least one intact femur was prepared from each sacrificed animal (not pretreated with a spindle inhibitor). A suitable instrument was used to sever the pelvic bones and lower leg.
The femur was separated from muscular tissue. The lower-leg stump, including the knee and all attached soft parts, was separated in the distal epiphyseal cartilage by a gentle pull at the distal end. The proximal end of the femur was opened at its extreme end with a suitable instrument, e.g. fine scissors, making visible a small opening in the bone-marrow channel. A suitable tube was filled with sufficient fetal calf serum. A small amount of serum was drawn from the tube into a
suitable syringe with a thin cannula. The cannula was pushed into the open end of the marrow
cavity. The femur was then completely immersed in the calf serum and pressed against the wall of the tube, to prevent its slipping off. The contents were then flushed several times and the bone
marrow was passed into the serum as a fine suspension. Finally, the flushing might be repeated from the other end, after it had been opened. The tube containing the serum and bone marrow was centrifuged in a suitable centrifuge at approximately 1000 rpm for five minutes.
The supernatant was removed with a suitable pipette (e.g. Pasteur pipette), leaving only a small remainder. The sediment was mixed to produce a homogeneous suspension. One drop of the viscous suspension was placed on a well cleaned slide and spread with a suitable object, to allow
proper evaluation of the smear. The labeled slides were dried overnight. If fresh smears needed to be stained, they needed to be dried with heat for a short period.
The Staining of Smears:
The smears were stained automatically with an Ames Hema-Tek Slide Stainer from the Miles Company. The slides were then "destained" with methanol, rinsed with deionized water, and left to dry.
The Covering of Smears:
Following this treatment, the smears were transferred to a holder. A cuvette was filled with xylene, into which the holder was immersed for approximately ten minutes. The slides were removed singly (e.g. with tweezers) to be covered. A small amount of covering agent was taken from a bottle with a suitable object (e.g. glass rod) and applied to the coated side of the slide. A cover glass was then placed in position without trapping bubbles. The slides were not evaluated until the covering agent had dried. - Evaluation criteria:
- Coded slides were evaluated using a light microscope at a magnification of about 1000. Micronuclei appear as stained chromatin particles in the a nucleated erythrocytes. They can be distinguished from artifacts by varying the focus.
If the ratio for a single animal amounts to distinctly more than 3000 normochromatic erythrocytes per 1000 polychromatic ones, or if such a ratio seems likely without other animals in the group showing similar effects, then the case may be regarded as pathological and unrelated to treatment, and the animal may be omitted from the evaluation. A test was considered positive if, at any of the intervals, there was a relevant and significant increase in the number of polychromatic erythrocytes showing micronuclei in comparison to the negative control. test was considered negative if there was no relevant or significant increase in the rate of micronucleated polychromatic erythrocytes at any time. A test was also considered negative if there was a significant increase in that rate which, according to the laboratory's experience was within the range of negative controls.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- A negative result is reported for a mouse bone marrow micronucleus assay with propineb, using single doses of 500 and 700 mg/kg bw (sampling at 16, 24 and 48 hours).
Any other information on results incl. tables
There is evidence of target tissue exposure (altered NCE:PCE ratio) and clear evidence of systemic toxicity, including mortality at 700 mg/kg bw. Furthermore, target tissue exposure can be assumed due to the dosing method used.
Applicant's summary and conclusion
- Conclusions:
- No relevant indications of a clastogenic effect of propineb were found after a single intraperitoneal treatment with 500 and 700 mg/kg bw.
- Executive summary:
The micronucleus test was employed to investigate propineb in male and female mice for a possible clastogenic effect on the chromosomes of bone-marrow erythroblasts in two independent experiments. The known clastogen and cytostatic agent, cyclophosphamide, served as positive control. The treated animals received a single intraperitoneal administration of either a propineb product (containing 70% propineb) or cyclophosphamide.
The femoral marrow of groups treated with propineb was prepared 16, 24 and 48 hours after administration. All negative and positive control animals were sacrificed after 24 hours. The doses of propineb were 500 mg/kg bw in the first trial and 700 mg/kg bw in the second experiment. For the positive control, cyclophosphamide, 20 mg/kg body weight were used for both studies. The animals treated with propineb showed symptoms of toxicity after administration. Two of forty animals died before the end of the test due to the acute intraperitoneal toxicity of 700 mg/kg bw propineb. There was an altered ratio between polychromatic and normochromatic erythrocytes. No relevant indications of a clastogenic effect of propineb were found after a single intraperitoneal treatment with 500 and 700 mg/kg.
Cyclophosphamide, the positive control, had a clear clastogenic effect, as is shown by the biologically relevant increase in polychromatic erythrocytes with micronuclei. The ratio of polychromatic to normochromatic erythrocytes was not altered.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.